Anemia en la enfermedad inflamatoria intestinal: un objetivo subestimado

Rodrigo Quera*, Paulina Núñez, Lilian Flores

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva


Anemia is the most common extraintestinal manifestation of inflammatory bowel disease (IBD). Although there are several causes of anemia in IBD, the two most frequent etiologies are iron deficiency anemia and anemia of chronic disease. Despite the high prevalence of anemia in IBD and its significant impact on patient´s quality of life, this complication is still underdiagnosed and undertreated by providers. Active screening for anemia, structured assessment, comprehensive management, and multidisciplinary collaboration are needed in IBD patients. The cornerstone of anemia management depends on the underlying etiology along with normalization of inflammatory activity. Although, oral iron is effective for the treatment of mild iron deficiency-related anemia, intravenous iron formulations have a good safety profile and can be used as first-line therapy in patients with active IBD, severe anemia and previous intolerance prior to oral iron. After proper treatment of anemia, careful monitoring is necessary to prevent its recurrence. Herein, we discuss the etiology, screening, diagnosis, therapy selection, and follow-up for anemia in IBD.

Título traducido de la contribuciónAnemia in inflammatory bowel disease
Idioma originalEspañol
Páginas (desde-hasta)1063-1074
Número de páginas12
PublicaciónRevista Medica de Chile
EstadoPublicada - ago. 2022

Nota bibliográfica

Publisher Copyright:
© 2022 Sociedad Medica de Santiago. All rights reserved.

Palabras clave

  • Anemia
  • Inflammatory Bowel Diseases
  • Iron Deficiencies
  • Quality of Health Care
  • Vitamin B12 Deficiency


Profundice en los temas de investigación de 'Anemia en la enfermedad inflamatoria intestinal: un objetivo subestimado'. En conjunto forman una huella única.

Citar esto